Navigation Links
Sheller, P.C. Law Firm Instrumental in Pfizer's $2.3 Billion Settlement Today in Largest Pharmaceutical Whistleblower Case in History
Date:9/2/2009

oximately $4.4 billion worth of Pfizer's Zyvox was sold from 2000 to 2008, according to the company's annual reports. Explosive sales increases averaged close to 200 percent per year. They also caused public health concerns of drug resistance and immunity, according to court and public documents.

"The widespread off-label promotion of Zyvox by Pfizer for non-FDA approved purposes poses a grave public risk because it increases the risk that linezolid resistant eterococci will develop and also increases the risk that more Zyvox resistant bacterial strains will develop," according to Sheller's complaint.

In a 2007 letter to physicians, the New York State Health Department warned that, "Overuse of [Zyvox] will accelerate the development of resistance and limit its overall effectiveness."

"Let's hope this case helps put the brakes on the overuse of Zyvox so the New York State Health Department's warning doesn't come true and patients can continue to be treated effectively for the specific uses for which this drug is effective and approved," said James J. Pepper, Esq., of Sheller, P.C. who also represents the relator.

In its July 2005 Warning Letter, the FDA stated that Pfizer's ad misbranded Zyvox, made misleading and unsubstantiated implied superiority claims, and omitted important safety information. Although it paid lip service to the FDA in response to the letter, Pfizer continued to make claims to physicians that Zyvox was superior to vancomycin, according to Pepper. Zyvox costs approximately tens times as much as the generic vancomycin.

"Our client had a tremendous amount of information about the illegal marketing behind Zyvox that proved invaluable in making the case. We investigated his allegations and then filed a complaint under seal in federal court. As a result of what he observed and the careful cooperation our office had with federal and state authorities,
'/>"/>

SOURCE Sheller, P.C. Law Firm
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Thelen Instrumental in Closing $1 Billion Outsourcing Deal for Client Harvard Pilgrim Health Care
2. Hospital infections cost $1 billion in lost bed days
3. MarketsandMarkets: Global Emerging Lighting Technologies Market Worth US$112.2 Billion by 2014
4. Increasing Health Center Capacity by 20 Million Patients Could Save More Than $200 Billion Over the Next Decade
5. U.S. Compression Therapy Market to Reach $1.16 Billion in 2015, Finds Frost & Sullivan
6. MarketsandMarkets: Global Biomarker Market Worth US$ 20.5 Billion by 2014
7. Cardinal Health Announces $1.2 Billion Debt Tender Offer
8. MarketsandMarkets: Top Ten Medical Device Technologies Market Worth $454.3 Billion by 2014
9. New Study of House Health Reform Bill: California Faces Over $3.7 Billion in Medicare-Funded Nursing Home Cuts Over Ten Years
10. New Study of House Health Reform Bill: Minnesota Faces Over $654 Billion in Medicare-Funded Nursing Home Cuts Over Ten Years
11. New Study of House Health Care Reform Bill: Texas Faces Over $2.7 Billion in Medicare-Funded Nursing Home Cuts Over Ten Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 Insuranceservicecompany.com has released a new ... an investment tool. , Whole life insurance can provide ... be used as an investment tool. Clients can save money ... account. , A whole life insurance plan features a ... In order for this policy to be profitable, clients should ...
(Date:9/16/2014)... is partly caused by lapses in a very specific ... of Waterloo study. , The study, published in ... first to conclusively link reduced operation of the dorsolateral ... , "It has long been thought that the dorsolateral ... in check," said Professor Peter Hall, senior author on ...
(Date:9/16/2014)... Acute Cardiovascular Care 2014 is the event of the ... is the annual meeting of the Acute Cardiovascular Care ... and takes place 18-20 October in Geneva, Switzerland. ... Acute cardiovascular care is the specialty of cardiology dealing ... heart attack, cardiac arrest, and acute heart failure. The ...
(Date:9/16/2014)... is available in French . ... by pediatricians and researchers at Sainte-Justine University Hospital Research ... the prestigious medical journal Nature Medicine on ... migrates to the nucleus of nerve cells in the ... opens the possibility of developing new, more selective drugs ...
(Date:9/16/2014)... Dairy is considered ... daily consumption of 2-4 portions of milk-based products such as ... well known that dairy products contain calcium and minerals good ... may also have beneficial effects on metabolic health and can ... 2 diabetes. , Curious about these impacts, researchers from ...
Breaking Medicine News(10 mins):Health News:Whole Life Insurance Can Be A Good Investment Tool for Retirement! 2Health News:Caving to cravings? Indulging in junk food linked to lapses in brain function 2Health News:ACCA congress: Ensuring a rapid response to cardiac emergencies 2Health News:ACCA congress: Ensuring a rapid response to cardiac emergencies 3Health News:More cheese, please! News study shows dairy is good for your metabolic health 2
... data is showing a dramatic,reduction in the accidental ... more on one group,s 20-year effort to protect ... from Safe Kids Worldwide at:, http://media.medialink.com/WebNR.aspx?story=35058 , ... and,photos for free and unrestricted use at ...
... Brown & Toland Medical Group,today announced a strong financial ... on total revenues of $235 million., The medical ... performance and other related bonuses from health plans. The,medical ... $8.2,million in bonus payments to eligible physicians. In 2007 ...
... seem to cause drop in heart rate variability, researchers ... of a small study show that the electromagnetic field ... babies, Italian researchers report. , Whether these changes in ... could have implications for premature infants who can spend ...
... the Only Treatment Approved to Both Reduce Exacerbations ... ... 30 The,U.S. Food and Drug Administration today approved Advair ... powder),for the reduction of exacerbations in patients with chronic obstructive,pulmonary ...
... better way to distinguish acute leukemia patients who require aggressive ... therapy for cure., The study is published in the May ... an accompanying editorial. , Researchers say that changes in levels ... the kinds and amount of proteins they make, might predict ...
... April 30 Allscripts, the leading,provider of clinical ... improve healthcare, today announced results for the three,months ... ), Total revenue for the three months ... $65.0 million for the same period last year,increasing ...
Cached Medicine News:Health News:Brown & Toland Announces 2007 Financial Results 2Health News:Incubators Affect Newborns' Heart Rates 2Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 2Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 3Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 4Health News:Molecular change may reveal risk of leukemia relapse 2Health News:Molecular change may reveal risk of leukemia relapse 3Health News:Allscripts Reports First Quarter 2008 Results 2Health News:Allscripts Reports First Quarter 2008 Results 3Health News:Allscripts Reports First Quarter 2008 Results 4Health News:Allscripts Reports First Quarter 2008 Results 5Health News:Allscripts Reports First Quarter 2008 Results 6Health News:Allscripts Reports First Quarter 2008 Results 7Health News:Allscripts Reports First Quarter 2008 Results 8Health News:Allscripts Reports First Quarter 2008 Results 9Health News:Allscripts Reports First Quarter 2008 Results 10
(Date:9/15/2014)... 2014 /CNW/ - Health Minister Rona Ambrose today ... for donation over $2.5 million in personal protective equipment (PPE) ... global response to the Ebola outbreak in West ... shortage of equipment in the affected countries and has appealed ... in the affected countries. Personal protective equipment ...
(Date:9/15/2014)... , Sept. 15, 2014 /PRNewswire/ -  Pivotal Therapeutics ... specialty pharmaceutical company with a focus on Omega-3 ... today that the Board of Directors approved the ... an advisor at the close of business on Friday, ... of 1,000,000 common shares of the Company were ...
(Date:9/15/2014)... DALLAS , Sept. 15, 2014 /PRNewswire-iReach/ -- ... affects persons of all ages, but most commonly ... condition characterized by narrowing of the airways, leading ... the lungs come into contact with endogenous and ... of events, such as swelling of the airways, ...
Breaking Medicine Technology:Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 2Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 3Pivotal Therapeutics Grants Incentive Stock Options 2Asthma Market to Reach 161.02 million Cases in 10MM by 2023 2Asthma Market to Reach 161.02 million Cases in 10MM by 2023 3Asthma Market to Reach 161.02 million Cases in 10MM by 2023 4Asthma Market to Reach 161.02 million Cases in 10MM by 2023 5
... VIVUS, Inc. (Nasdaq: VVUS ) announced today ... the U.S. Food and Drug Administration (FDA) regarding its ... QNEXA® (phentermine/topiramate) Controlled-Release Capsules. The FDA issued the CRL ... approved in its present form.  The application seeks the ...
... Corporation (Nasdaq: THOR ), a world leader ... and restore failing hearts, said revenues from continuing operations ... versus the third quarter of 2009. Results ... first nine months of 2010 and 2009 exclude contributions ...
Cached Medicine Technology:FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 2FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 3FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 4FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 5Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 2Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 3Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 4Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 5Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 6Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 7Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 8Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 9Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 10Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 11Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 12Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 13Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 14Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 15Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 16
Inquire...
... Roches patented polymerase chain reaction (PCR) ... technology, is an essential component of Roches ... PCR allows minute amounts of selected unique ... into billions of copies (that is, to ...
... Introducing BenchMark XT® the only fully ... flexibility you need to expand your ... improve your slide turnaround time. All ... choose how to use the BenchMark ...
... Reicherts new ATP Auto Non-Contact Tonometer / ... / pachymeter, combining the measurement of IOP ... response to numerous clinical studies that have ... thickness as well as intraocular pressure in ...
Medicine Products: